Thirty Years of Research on the Dawn Phenomenon: Lessons to Optimize Blood Glucose Control in Diabetes
暂无分享,去创建一个
P. Lucidi | F. Porcellati | G. Bolli | C. Fanelli | Francesca Porcellati | Paola Lucidi | Geremia B Bolli | Carmine G Fanelli
[2] D. Owens,et al. Beyond the era of NPH insulin--long-acting insulin analogs: chemistry, comparative pharmacology, and clinical application. , 2008, Diabetes technology & therapeutics.
[3] G. Boden,et al. Evidence for a Circadian Rhythm of Insulin Sensitivity in Patients With NIDDM Caused by Cyclic Changes in Hepatic Glucose Production , 1996, Diabetes.
[4] Maria Inês Schmidt,et al. Fasting Early Morning Rise in Peripheral Insulin: Evidence of the Dawn Phenomenon in Nondiabetes , 1984, Diabetes Care.
[5] P. Cryer,et al. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion. , 1985, The New England journal of medicine.
[6] P. De Feo,et al. The dawn phenomenon in Type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity , 2004, Diabetologia.
[7] P. Home,et al. Night-time metabolic changes in normal subjects in the absence of the dawn phenomenon. , 1988, Diabete & metabolisme.
[8] M. Rendell,et al. The Dawn Phenomenon, an Early Morning Glucose Rise: Implications for Diabetic Intraday Blood Glucose Variation , 1981, Diabetes Care.
[9] D. Matthews,et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach , 2012, Diabetes Care.
[10] P. Brunetti,et al. Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon , 1986, Diabetologia.
[11] G. Bolli,et al. The "dawn phenomenon"--a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. , 1984, The New England journal of medicine.
[12] S. Inzucchi,et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379 , 2013, Diabetes Care.
[13] P. Brunetti,et al. Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in Type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning , 2004, Diabetologia.
[14] P. Brunetti,et al. Demonstration of a Dawn Phenomenon in Normal Human Volunteers , 1984, Diabetes.
[15] Salim Yusuf,et al. Basal insulin and cardiovascular and other outcomes in dysglycemia. , 2012, The New England journal of medicine.
[16] E. Volpi,et al. Evidence of Increased Systemic Glucose Production and Gluconeogenesis in an Early Stage of NIDDM , 1997, Diabetes.
[17] W. Blackard,et al. Pump-induced Insulin Aggregation: A Problem with the Biostator , 1985, Diabetes.
[18] J. Pickup,et al. Rarity of a Marked “Dawn Phenomenon” in Diabetic Subjects Treated by Continuous Subcutaneous Insulin Infusion , 1985, Diabetes Care.
[19] J. Radziuk,et al. Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour? , 2006, Diabetologia.